FDA Grants Accelerated Approval to Voceryq for Recurrent Respiratory Papillomatosis by Madaline Spencer| Published on: Nov 3, 2026

https://checkrare.com/fda-grants-accelerated-approval-to-voceryq-for-recurrent-respiratory-papillomatosis/ FDA Grants Accelerated Approval to Voceryq for Recurrent Respiratory Papillomatosis by Madaline Spencer| Published on: Nov 3, 2026 The US Food and Drug Administration (FDA) has granted accelerated approval to Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd), previously referred to as INO-3107, to reduce the frequency of surgery in adults with recurrent respiratory papillomatosis (RRP).